Global Orthobiologics Market 2016-2020 - Product Image

Global Orthobiologics Market 2016-2020

  • ID: 3623640
  • Report
  • Region: Global
  • 76 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AlloSource
  • AMEDICA
  • Arthrex
  • Biomimetic Therapeutics
  • Bone Therapeutics
  • DePuy Synthes
  • MORE
About Orthobiologics

Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Orthobiologic products are obtained from naturally occurring materials. These products help treat people with long-term disabling musculoskeletal disorders and injuries. Innovations in orthobiologics led to the development of bone grafts and tissue regeneration products that accelerate the bone healing process, reducing hospital visits, and stays.

The analysts forecast the global orthobiologics market to grow at a CAGR of 7.03% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global orthobiologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:

- Stem cells
- Bone morphogenetic proteins
- Synthetic bone grafts
- Viscosupplements
- Demineralized bone matrix
- Allografts

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Orthobiologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors:

- DePuy Synthes
- Medtronic
- Sanofi
- Stryker
- Zimmer Biomet

Other prominent vendors:

- Alphatec Spine
- AlloSource
- AMEDICA
- Anika Therapeutics
- Arthrex
- Baxter
- BBS-Bioactive Bone Substitutes
- Berkeley Advanced Biomaterial
- Biomimetic Therapeutics
- Bioventus
- Bone Therapeutics
- Ceramisys
- Geistlich Bio-Oss
- Graftys
- Integra Life Sciences
- ISTO Technologies
- Keramat
- K2M
- NovaBone
- Orthogem
- Orthofix International
- OsteoMed
- RTI Surgical
- Sigma Graft
- Smith & Nephew
- Straumann
- Wright Medical
- Xtant Medical

Market drivers

- Rise in strategic partnerships for marketing
- For a full, detailed list, view the full report

Market challenges

- High cost of spine fusion surgery
- For a full, detailed list, view the full report

Market trends

- Funds to enhance orthobiologics
- For a full, detailed list, view the full report

Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AlloSource
  • AMEDICA
  • Arthrex
  • Biomimetic Therapeutics
  • Bone Therapeutics
  • DePuy Synthes
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Funding for orthobiologics development
  • Orthobiologic products under clinical trial
PART 06: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 07: Market segmentation by product
  • Global orthobiologics market by stem cells
  • Global orthobiologics market by bone morphogenetic proteins
  • Global orthobiologics market by synthetic bone grafts
  • Global orthobiologics market by viscosupplements
  • Global orthobiologics market by demineralized bone matrix
  • Global orthobiologics market by allografts
PART 08: Market segmentation by procedure
  • Spinal fusion surgery
  • Orthopedic trauma and reconstruction surgery
PART 09: Geographical segmentation
  • Orthobiologics market in Americas
  • Orthobiologics market in EMEA
  • Orthobiologics market in APAC
PART 10: Market drivers
  • Popularity of spinal fusion surgeries
  • Rise in strategic partnerships for marketing
  • Prevalence of arthritis
PART 11: Impact of drivers

PART 12: Market challenges
  • High cost of spinal fusion surgery
  • Product side effects and FDA scrutiny
  • Poor performance of bone graft substitute
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Funds to enhance orthobiologics
  • Product development in collaboration with research institutes
  • Increase in M&A
PART 15: Vendor landscape
  • Competitive scenario
  • Market share analysis
  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
PART 17: About Author

List of Exhibits

Exhibit 01: Product offerings 7
Exhibit 02: Funding for orthobiologics development
Exhibit 03: Global orthobiologics market segmentation by product and procedure
Exhibit 04: Global orthobiologics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global orthobiologics market by product 2015
Exhibit 07: Global orthobiologics market by stem cells 2015-2020 ($ millions)
Exhibit 08: Global orthobiologics market by bone morphogenetic proteins 2015-2020 ($ millions)
Exhibit 09: Global orthobiologics market by synthetic bone grafts 2015-2020 ($ millions)
Exhibit 10: Global orthobiologics market by viscosupplements 2015-2020 ($ billions)
Exhibit 11: Global orthobiologics market by demineralized bone matrix 2015-2020 ($ millions)
Exhibit 12: Global orthobiologics market by allografts 2015-2020 ($ millions)
Exhibit 13: Global orthobiologics market by procedure 2015
Exhibit 14: Global orthobiologics market by geography 2015
Exhibit 15: Orthobiologics market in Americas 2015-2020 ($ billions)
Exhibit 16: Orthobiologics market in EMEA 2015-2020 ($ billions)
Exhibit 17: Orthobiologics market in APAC 2015-2020 ($ millions)
Exhibit 18: Global orthobiologics market by geography 2015-2020
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Ranking of vendors 2015
Exhibit 22: Competitive scenario of vendors 2015
Exhibit 23: Comparative analysis of vendors and their orthobiologic products
Exhibit 24: Collaboration between vendors and universities or organizations
Exhibit 25: DePuy Synthes: Key takeaways
Exhibit 26: DePuy Synthes: Business segmentation
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: Medtronic: Business segmentation by revenue 2015
Exhibit 29: Sanofi: Key takeaways
Exhibit 30: Sanofi: Product revenue 2014
Exhibit 31: Sanofi: Product revenue comparison 2013 and 2014 ($ millions)
Exhibit 32: Stryker: Key takeaways
Exhibit 33: Stryker: Business segmentation by revenue 2014
Exhibit 34: Stryker: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: Stryker: Geographical segmentation by revenue 2014
Exhibit 36: Zimmer Biomet: Key takeaways
Exhibit 37: Zimmer Biomet: Business segmentation by revenue 2014
Exhibit 38: Zimmer Biomet: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Zimmer Biomet: Geographical segmentation by revenue 2014
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AlloSource
  • AMEDICA
  • Arthrex
  • Biomimetic Therapeutics
  • Bone Therapeutics
  • DePuy Synthes
  • MORE
New Report Released: – Global Orthobiologics Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Orthobiologics Market: DePuy Synthes, Medtronic, Sanofi, Stryker and Zimmer Biomet.

Other Prominent Vendors in the market are: Alphatec Spine, AlloSource, AMEDICA, Anika Therapeutics, Arthrex, Baxter, BBS-Bioactive Bone Substitutes Oy, Berkeley Advanced Biomaterial, Biomimetic Therapeutics, Bioventus, Bone Therapeutics, Ceramisys, Geistlich Bio-Oss, Graftys, Integra Life Sciences, ISTO Technologies, Keramat, NovaBone, Orthogem Limited, Orthofix International, OsteoMed, RTI Surgical, Sigma Graft, Smith & Nephew, Straumann, Wright Medical, and Xtant Medical.

Commenting on the report, an analyst from the research team said: “A major trend that is expected to boost the market growth during the forecast period is the increase in funds to enhance orthobiologics. Vendors in the market are extensively investing in research to develop a wide range of innovative products, strengthening their portfolio and successful commercialization of products. Such developments will lead to the growth of the orthobiologics market over the next five years.”

According to the report, forming strategic partnerships for marketing is one of the primary drivers of the market. Vendors form strategic partnerships to expand their businesses, extend their product offerings, and increase their market shares. These partnerships also help companies align their technologies with each other's innovative medical device portfolio.

Further, the report states that the high cost of spinal fusion surgeries is restricting the sales of orthobiologics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- DePuy Synthes
- Medtronic
- Sanofi
- Stryker
- Zimmer Biomet
- Alphatec Spine
- AlloSource
- AMEDICA
- Anika Therapeutics
- Arthrex
- Baxter
- BBS-Bioactive Bone Substitutes Oy
- Berkeley Advanced Biomaterial
- Biomimetic Therapeutics
- Bioventus
- Bone Therapeutics
- Ce
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll